• Pfizer bags approval for Neupogen biosimilar pharmatimes
    July 24, 2018
    Pfizer’s Neupogen biosimilar Nivestym has been approved by the US Food and Drug Administration and is expected to hit the market at a “significant discount” to its reference drug.
PharmaSources Customer Service